| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_f2d3599fb8f8f479dba95ca9bb504884 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D311-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-357
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-36
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-353
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D321-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P3-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D317-44 |
| filingDate |
2006-12-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9cac38668bec1ffda1289ed3be75278a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_bd513603fc1f9ac2316ec8b05decf1b2 |
| publicationDate |
2007-12-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
TW-200744579-A |
| titleOfInvention |
Use of benzo-fused heterocycle sulfamide derivatives for lowering lipids and lowering blood glucose levels |
| abstract |
The present invention is a use of one or more novel benzo-fused heterocycle sulfamide derivatives of formula (I) and formula (II) as defined for the manufacture of a medicament for the glucose related disorders and lipid related disorders. The present invention is further directed to uses of an anti-diabetic agent, and anti-lipid agent and / or an anti-obesity agent. |
| priorityDate |
2005-12-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |